$Tonix Pharmaceuticals (TNXP.US)$
When I look at posts from people managing their securities accounts from around 0.2, there are many opinions saying that this is just the beginning. I remind myself that trading Bio & Penny stocks is like a Gambling of either 0 or 1000. I tell myself that I have studied and go to bed 🫨.

$Tonix Pharmaceuticals (TNXP.US)$
With 50 million Short Sell contracts by hedge funds, there may be a temporary decline, but in the long run, the stock price will rise.
Perhaps that decline could be the final Buy opportunity.
Regarding delisting, I believe there is no issue as long as the stock price remains above $1.

$Tonix Pharmaceuticals (TNXP.US)$
S individual investors' panic selling shows a really lack of investment sense~.
It's really a waste to panic and release positions when the price is falling.
A significant drop is not an excellent buying opportunity, isn't it?
When the price goes down, I think you should bravely increase your buying position.
Please watch. When you confirm that individual investors' positions are decreasing, hedge funds will quickly push the price up.
Therefore, I will pick up the downside from now on and continue to increase my buying.
Even if the stock price drops, the intrinsic value of the company called Tonix remains unchanged, so you can rest assured to keep buying.

$Tonix Pharmaceuticals (TNXP.US)$
After FDA acceptance decision, if all goes well, the approval decision will be made in mid-August.
In that case, a new drug for fibromyalgia is coming after a 15-year absence!
Considering that over 10 million patients worldwide are waiting for this new drug, it is impossible to predict how high the stock price will rise.

$Tonix Pharmaceuticals (TNXP.US)$
Thank you TNXP
I earned a large amount of money for the first time.

$Tonix Pharmaceuticals (TNXP.US)$
Circuit breaker?

$Tonix Pharmaceuticals (TNXP.US)$
Finally released?
The new drug application (NDA) for TNX-102 SL for the management of fibromyalgia has been submitted to the FDA, with NDA acceptance expected in December 2024, FDA previously granted fast track designation, and FDA's decision on approval in 2025 is anticipated.
If approved by the FDA, TNX-102 SL will become the first member of a new group of analgesics for fibromyalgia, reappearing after over 15 years as a 🌸new drug🌸 for fibromyalgia treatment.